WuXi ATU and GeneMedicine sign development and manufacturing agreement for oncolytic virus products

This article was originally published here

This is the first international Chemistry, Manufacturing and Controls (CMC) development and manufacturing project empowered by the Oncolytic Virus contract development and manufacturing organization (CDMO) platform, which has

The post WuXi ATU and GeneMedicine sign development and manufacturing agreement for oncolytic virus products appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply